feed,title,long_url,short_url
SeekingAlpha,FDA extends review period for Incyte's ruxolitinib sNDA,https://seekingalpha.com/news/3704013,
SeekingAlpha,Anavex Life's late-stage ANAVEX2-73 study in Alzheimerâ€™s exceeds target enrollment,https://seekingalpha.com/news/3704012,
SeekingAlpha,Summit Therapeutics to join Russell 3000 Index,https://seekingalpha.com/news/3704011,
